期刊文献+

IL-18与非酒精性脂肪肝的研究进展 被引量:6

原文传递
导出
摘要 白介素18(IL-18)是一种前炎症性细胞因子,具有重要的免疫调节和损伤肝细胞的作用,可能在非酒精性脂肪性肝病(NAFLD)中起着重要作用。现就IL-18的来源、生物学效用以及其与NAFLD的发生、发展及预后关系的研究进展作一综述。
出处 《热带医学杂志》 CAS 2012年第10期1297-1299,共3页 Journal of Tropical Medicine
基金 广西科技厅自然科学基金(桂科自0991263) 桂林市科学研究与技术开发计划项目(20090539) 广西卫生厅自筹经费科研课题项目(Z2009036)
  • 相关文献

参考文献26

  • 1Wong VW, Wong GL, Yip GW, et al.Coronary artery diseaseand cardiovascular outcomes in patients with non-alcoholic fattyliver disease [J].Gut,2011,60( 12) : 1721-1727.
  • 2Day CP.Non-alcoholic fatty liver disease:a massive problem[J].Clin Med,2011,11(2):176-178.
  • 3Wong VW,Wong GL,Tsang SW, et al.High prevalence ofcolorectal neoplasm in patients with non-alcoholic steatohepatitis[J].Gut,2011,60(6) :829-836.
  • 4Ji G,Zhao X,Leng L,et al.Comparison of dietary control andatorvastain on high fat diet induced hepatic steatosis andhyperlipidemia in rats [J].Lipids Health Dis,2011,10:23.
  • 5Dinarello CA. Interleukin-18 and the pathogenesis ofinflammatory disease[ J ].Semin Nephrol, 2007,27 (7) : 98-114.
  • 6Hata H, Yoshimoto T, Hayashi N, et al.IL-18 together with anti-CD3 antibody induces human Thl cells to produce Thl andTh2 cytokines and IL-18 [J]. Immunol,2004,16 (12) : 1733 -1739.
  • 7Huang Y,Lei Y,Zhang H.Role of interleukin-18 in humannatural killer cell is associated with interleukin-2 [J].MolImmunol ,2010,47(16): 2604-2610.
  • 8Budak F,Uzaslan EK,Gangiir S,et al.Increased pleural solublefaslingand levels in tuberculosis pleurisy and its relation with T-helper type 1 cytokines[J].Lung,2008,186(5) :337-343.
  • 9Dinarello CA.Interleukin-18 and the pathogenesis of inflammatorydisease [J].Semin Nephrol,2007 ,27 ( 1) : 98-114.
  • 10金春花,范能光,张文,刘建华,夏振华,张丽娟.2型糖尿病患者合并非酒精性脂肪肝与胰岛素抵抗的相关性[J].热带医学杂志,2011,11(1):65-67. 被引量:23

二级参考文献114

共引文献67

同被引文献74

  • 1John Vizuete,Alfredo Camero,Mazyar Malakouti,Karthik Garapati,Julio Gutierrez.Perspectives on Nonalcoholic Fatty Liver Disease:An Overview of Present and Future Therapies[J].Journal of Clinical and Translational Hepatology,2017,5(1):67-75. 被引量:13
  • 2Somaya Albhaisi,Danny Issa,Naim Alkhouri.Non-alcoholic fatty liver disease: a pandemic disease with multisystem burden[J].Hepatobiliary Surgery and Nutrition,2018,7(5):389-391. 被引量:7
  • 3Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1513
  • 4范建高.非酒精性脂肪性肝病的流行率[J].中国医师进修杂志(内科版),2006,29(9):1-2. 被引量:33
  • 5Minakari M,Molaei M,Shalmani HM,et al.Liver steatosis in patients with chronic hepatitis B infection:host and viral risk factors[J].Eur J Gastroenterol&Hepatol,2009,21(5):512-516.
  • 6Patel A,Harrison MD.Hepatitis C virus infection and nonalcoholicsteatohepatitis[J].Gastroenterol Hepatol(NY),2012,8(5):305-312.
  • 7Jin X,Chen YP,Yang YD,et al.Association between hepatic steatosis and entecavir treatment failure in chinese patients with chronic hepatitis B[J].Plos One,2012,7(3):e34198.
  • 8Fan JG,Farrell GC.Epidemiology of non-alcoholic fatty liver disease in China[J].J Hepatol,2009,50(1):204-210.
  • 9Fan JG.Impact of non-alcoholic fatty liver disease on accelerated metabolic complications[J].J Dig Dis,2008,9(2):63-67.
  • 10Vuppalanchi R,Chalasani N.Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis:selected practical issues in their evaluation and management[J].Hepatology,2009,49(1):306-317.

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部